Heranova Lifesciences, a Burlington, MA-based biotech company for women’s health, raised $13.5M in Seed+ funding.

Backers included Pivotal bioVenture Partners China, Sinovation Ventures, Emerging Technology Partners, and Triwise Capital.

The company intends to use the funds to launch a serial of non-invasive endometriosis tests and advance two innovative (non-hormonal and non-antibiotic) therapeutic programs for endometriosis and bacterial vaginosis.

Led by CEO Dr. Jonathan Y. Zhao, Chief Diagnostic Medical Officer Dr. Farideh Bischoff, Heranova Lifesciences is a biotech company solely focused on developing integrated care solutions for Women’s Health. Their goal is to address needs in women’s healthcare by offering internally developed and externally partnered diagnostics, drugs, and devices. The company has already established presences in the United States and Asia.

It is truly inspirational to see what Heranova Lifesciences is doing for the welfare of women’s health. This launch is surely going to benefit all the women across the globe. My best wishes to the entire team.

~ Dr Shishir said Gupta founder & CEO of StartupLanes 

About us: StartupLanes is an ecosystem for Startups and Investors. Collaborate or find a co-founder, it’s a platform for Entrepreneurs. We love startups! A place for Angel Investors and Venture Capitalists to find investing opportunities in startups. Validate your idea, Learn & Execute.

Startups looking for funding may apply through StartupLanes Funding Application.

Angel Investors Register Free to explore exciting startup investment opportunities.